{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:55:56Z","timestamp":1790744156367,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12098-020-03636-x","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T02:02:36Z","timestamp":1615600956000},"page":"819-823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Monogenic Lupus with IgA Nephropathy Caused by Spondyloenchondrodysplasia with Immune Dysregulation"],"prefix":"10.1007","volume":"88","author":[{"given":"Haseena","family":"Sait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishnan","family":"Gangadharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviral","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6624-082X","authenticated-orcid":false,"given":"Shubha R.","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"3636_CR1","doi-asserted-by":"publisher","first-page":"102361","DOI":"10.1016\/j.autrev.2019.102361","volume":"18","author":"O Omarjee","year":"2019","unstructured":"Omarjee O, Picard C, Frachette C, et al. Monogenic lupus: dissecting heterogeneity. Autoimmun Rev. 2019;18:102361.","journal-title":"Autoimmun Rev"},{"key":"3636_CR2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1189\/jlb.72.4.752","volume":"72","author":"GF Weber","year":"2002","unstructured":"Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol. 2002;72:752\u201361.","journal-title":"J Leukoc Biol"},{"key":"3636_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/ni1327","volume":"7","author":"ML Shinohara","year":"2006","unstructured":"Shinohara ML, Lu L, Bu J, et al. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol. 2006;7:498\u2013506.","journal-title":"Nat Immunol"},{"key":"3636_CR4","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","volume":"9","author":"JM Alperin","year":"2018","unstructured":"Alperin JM, Ortiz-Fern\u00e1ndez L, Sawalha AH. Monogenic lupus: a developing paradigm of disease. Front Immunol. 2018;9:2496.","journal-title":"Front Immunol"},{"key":"3636_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10875-016-0252-y","volume":"36","author":"TA Briggs","year":"2016","unstructured":"Briggs TA, Rice GI, Adib N, et al. Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey. J Clin Immunol. 2016;36:220\u201334.","journal-title":"J Clin Immunol"},{"key":"3636_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.rbr.2014.10.011","volume":"56","author":"LS da Silva","year":"2016","unstructured":"da Silva LS, Almeida BL, de Melo AK, de Brito DC, Braz AS, Freire EA. IgA nephropathy in systemic lupus erythematosus patients: case report and literature review. Rev Bras Reumatol Engl Ed. 2016;56:270\u20133.","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"3636_CR7","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1159\/000502579","volume":"44","author":"K Zhang","year":"2019","unstructured":"Zhang K, Li Q, Zhang Y, et al. Clinical significance of galactose-deficient IgA1 by KM55 in patients with IgA nephropathy. Kidney Blood Press Res. 2019;44:1196\u2013206.","journal-title":"Kidney Blood Press Res"},{"key":"3636_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/0961203309349384","volume":"19","author":"T Horino","year":"2010","unstructured":"Horino T, Takao T, Terada Y. IgA nephropathy in a patient with systemic lupus erythematosus. Lupus. 2010;19:650\u20134.","journal-title":"Lupus."},{"key":"3636_CR9","first-page":"467","volume":"25","author":"A Corrado","year":"2007","unstructured":"Corrado A, Quarta L, Di Palma AM, Gesualdo L, Cantatore FP. IgA nephropathy in systemic lupus erythematosus. Clin Exp Rheumatol. 2007;25:467\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"3636_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/cpt.936","volume":"104","author":"H Kim","year":"2018","unstructured":"Kim H, Brooks KM, Tang CC, et al. Pharmacokinetics, pharmacodynamics, and proposed dosing of the oral JAK1 and JAK2 inhibitor baricitinib in pediatric and young adult CANDLE and SAVI patients. Clin Pharmacol Ther. 2018;104:364\u201373.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-020-03636-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:25:51Z","timestamp":1671618351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-020-03636-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["3636"],"URL":"https:\/\/doi.org\/10.1007\/s12098-020-03636-x","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,13]]},"assertion":[{"value":"28 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}